Page last updated: 2024-12-05

tristearin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Tristearin, also known as glyceryl tristearate, is a saturated triacylglycerol (TAG) composed of three stearic acid molecules esterified to a glycerol molecule. It is a white, waxy solid at room temperature, and is the most common triglyceride found in animal fats. Tristearin is produced commercially by the hydrogenation of vegetable oils, and it has various applications in food, cosmetics, and pharmaceuticals. Its study is significant due to its role in understanding the properties of fats and oils, its potential as a renewable biofuel, and its potential health implications. '

tristearoylglycerol : A triglyceride that is glycerol in which all three hydroxy groups have been formally esterified with stearic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID11146
CHEBI ID45956
SCHEMBL ID9507
MeSH IDM0078926

Synonyms (69)

Synonym
octadecanoic acid, 1,2,3-propanetriyl ester
tristearin
stearic acid triglyceride
glycerol tristearate
spezialfett 118
stearoyl triglyceride
stearic triglyceride
hsdb 5690
dynasan 118
glyceryl tristearate
stearin
glycerol, trioctadecanoate
stearin, tri-
stearic acid triglycerin ester
trioctadecanoin
einecs 209-097-6
ai3-01633
1,2,3-propanetriol trioctadecanoate
1,2,3-trioctadecanoyl-glycerol
tg(18:0/18:0/18:0)
1,2,3-trioctadecanoyl-sn-glycerol
LMGL03010002
triacylglycerol
tristearoylglycerol
glyceryl tristearate, >=99%
68334-00-9
glyceryl tristearate, technical
2,3-di(octadecanoyloxy)propyl octadecanoate
555-43-1
G0212
c57h110o6
FT-0675675
ec 209-097-6
unii-p6ocj2551r
p6ocj2551r ,
octadecanoic acid, 1,1',1''-(1,2,3-propanetriyl) ester
propane-1,2,3-triyl tristearate
tristearin [ii]
tristearin [hsdb]
tristearin [mi]
glyceryl tristearate [fcc]
tristearin [inci]
glyceryl tristearate [nf]
AKOS015899779
vegetable oil, hydrogenated
glyceryl tri(octadecanoate-1-13c)
SCHEMBL9507
1,2,3-propanetriyl trioctadecanoate
kemester 6000 (salt/mix)
glycerol trioctadecanoate
2,3-bis(stearoyloxy)propyl stearate #
DTXSID8047503
trioctadecanoylglycerol
CHEBI:45956
propane-1,2,3-triyl trioctadecanoate
D10637
glyceryl tristearate (nf)
1-stearoyl-2-stearoyl-3-stearoyl-glycerol
tristearin, european pharmacopoeia (ep) reference standard
Q425640
AS-11714
mfcd00036230
beta-tristearin (sss)
beta-1,2,3-tri-octadecanoyl-glycerol
D90727
propane-1,2,3-triyltristearate
CS-0092148
HY-127035
?1,2,3-tristearoyl glycerol

Research Excerpts

Bioavailability

To control the oral bioavailability of curcumin, we fabricated solid lipid nanoparticles (SLNs) using tristearin and polyethylene glycol (PEG)ylated emulsifiers. To enhance in vivo efficacy and oralBioavailability of aripiprazole, SLNs were developed using trstearin as solid lipid.

ExcerptReferenceRelevance
" Tween 80-emulsified SLNs showed enhanced intestinal absorption, lymphatic uptake, and relative oral bioavailability of docetaxel compared with Taxotere in rats."( Surface-modified solid lipid nanoparticles for oral delivery of docetaxel: enhanced intestinal absorption and lymphatic uptake.
Cho, HJ; Kim, DD; Park, JW; Yoon, IS, 2014
)
0.4
"Associating protein with nanoparticles is an interesting strategy to improve their bioavailability and biological activity."( Microencapsulated SLN: An innovative strategy for pulmonary protein delivery.
Almeida, AJ; Gaspar, DP; Gonçalves, L; Lino, PR; Remuñán-López, C; Serra, C; Taboada, P, 2017
)
0.46
" To enhance in vivo efficacy and oral bioavailability of aripiprazole, aripiprazole-loaded solid lipid nanoparticles (SLNs) were developed using tristearin as solid lipid."( Enhancement of In Vivo Efficacy and Oral Bioavailability of Aripiprazole with Solid Lipid Nanoparticles.
Sinha, VR, 2018
)
0.68
"To control the oral bioavailability of curcumin, we fabricated solid lipid nanoparticles (SLNs) using tristearin and polyethylene glycol (PEG)ylated emulsifiers."( Enhancing the oral bioavailability of curcumin using solid lipid nanoparticles.
Ban, C; Choi, YJ; Han, JY; Jo, M; Kim, JH; Kweon, DH; Lee, KW; Park, YH, 2020
)
0.77
" This work provides useful insights into the rational design of NLCs to optimize the bioavailability of the loaded agent."( The influence of oil composition on the transformation, bioaccessibility, and intestinal absorption of curcumin in nanostructured lipid carriers.
Chai, Z; Cui, L; Feng, J; Huang, M; Huang, W; Li, C; Li, Y, 2020
)
0.56

Dosage Studied

ExcerptRelevanceReference
"Bupivacaine lipid microparticles were prepared and evaluated as a parenteral sustained-release dosage form for postoperative pain management."( Effect of solid state transition on the physical stability of suspensions containing bupivacaine lipid microparticles.
Bandopadhyay, R; Deng, JS; Li, LC; Song, JF; Wurster, DE; Zhu, L, 2005
)
0.33
" These correlations help to understand the solid-state behaviour of lipids and to avoid process conditions which lead to unstable dosage forms."( Understanding the solid-state behaviour of triglyceride solid lipid extrudates and its influence on dissolution.
Kleinebudde, P; Strachan, CJ; Windbergs, M, 2009
)
0.35
"Different combinations of monoacid triglycerides and polyethylene glycol powders of different molecular weights were successfully extruded below their melting temperatures as a basis for oral dosage forms."( Influence of structural variations on drug release from lipid/polyethylene glycol matrices.
Kleinebudde, P; Strachan, CJ; Windbergs, M, 2009
)
0.35
" The results of this study help in understanding the complex solid-state behaviour of solid lipid extrudates with different composition and to manufacture suitable lipid-based oral dosage forms."( Influence of the composition of glycerides on the solid-state behaviour and the dissolution profiles of solid lipid extrudates.
Kleinebudde, P; Strachan, CJ; Windbergs, M, 2009
)
0.35
"The purpose of this work was to develop a new pressure-sensitive dosage form that breaks and releases its content in a fasted stomach at the predominant pressure at the pylorus."( Development of a pressure-sensitive glyceryl tristearate capsule filled with a drug-containing hydrogel.
Bock, M; Garbacz, G; Glöckl, G; Weitschies, W; Wilde, L, 2014
)
0.4
" This work brings new insights on the micrometric properties of solid lipid dosage forms, being an important step to prevent the overuse of excipients with unknown toxicity."( Role of Lipid Blooming and Crystallite Size in the Performance of Highly Soluble Drug-Loaded Microcapsules.
Becker, K; Haack, D; Lochmann, D; Lopes, DG; Salar-Behzadi, S; Stehr, M; Zimmer, A, 2015
)
0.42
"Glycerides are widely employed as solid matrices in a range of pharmaceutical intermediates and dosage forms."( Control of API release with matrix polymorphism in tristearin microspheres.
Cape, JL; Klaus, ND; Lyon, DK; Pluntze, AM, 2023
)
1.16
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (1 Product(s))

Product Categories

Product CategoryProducts
Beauty & Personal Care1

Products

ProductBrandCategoryCompounds Matched from IngredientsDate Retrieved
Euthymol Original Mouthwash -- 16.9 fl ozEuthymolBeauty & Personal Carecitric acid, citric acid, red 33, glyceryl stearate, glycerin, menthol, methyl salicylate, poloxamer 407, sodium benzoate, sodium citrate, tristearin2024-11-29 10:47:42

Roles (2)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
Caenorhabditis elegans metaboliteA nematode metabolite produced by Caenorhabditis elegans.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
triacylglycerol 54:0
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (3)

PathwayProteinsCompounds
Triacylglycerol metabolism TG(18:0/18:0/18:0)1414
Triacylglycerol Degradation TG(18:0/18:0/18:0)511
De Novo Triacylglycerol Biosynthesis TG(18:0/18:0/18:0)513

Research

Studies (133)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (6.02)18.7374
1990's12 (9.02)18.2507
2000's26 (19.55)29.6817
2010's75 (56.39)24.3611
2020's12 (9.02)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 63.80

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index63.80 (24.57)
Research Supply Index4.92 (2.92)
Research Growth Index5.08 (4.65)
Search Engine Demand Index105.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (63.80)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (1.49%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (0.75%)4.05%
Observational0 (0.00%)0.25%
Other131 (97.76%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]